During skeletal mineralization, the sodium-phosphate co-transporter PiT1Slc20a1 is assumed to meet the phosphate requirements of bone-forming cells, although evidence is missing. Here, we used a conditional gene deletion approach to determine the role of PiT1 in growth plate chondrocytes. We show that PiT1 ablation shortly after birth generates a rapid and massive cell death in the center of the growth plate, together with an uncompensated endoplasmic reticulum (ER) stress, characterized by morphological changes and increased Chop, Atf4, and Bip expression. PiT1 expression in chondrocytes was not found at the cell membrane but co-localized with the ER marker ERp46, and was upregulated by the unfolded protein response cascade. In addition, we identified the protein disulfide isomerase (Pdi) ER chaperone as a PiT1 binding partner and showed that PiT1 ablation impaired Pdi reductase activity. The ER stress induced by PiT1 deficiency in chondrocytes was associated with intracellular retention of aggrecan and vascular endothelial growth factor A (Vegf-A), which was rescued by overexpressing a phosphate transport-deficient mutant of PiT1. Our data thus reveal a novel, Pi-transport independent function of PiT1, as a critical modulator of ER homeostasis and chondrocyte survival during endochondral ossification.
Introduction
I n the skeleton, most of the bones form through endochondral ossification. During this complex and spatially regulated process, chondrocytes synthesize an abundant collagen and proteoglycan-rich extracellular matrix (ECM) template that will be ultimately calcified through the deposition of apatitic calcium-phosphate (Pi) crystals. (1) Although the precise mechanisms of crystal formation and deposition are still debated, cellular uptake of Ca and Pi by mineralizing cells is a prerequisite to the mineralization process and is tightly controlled by specialized membrane proteins. (2, 3) PiT1/Slc20a1 was originally identified as a retrovirus receptor (4) and later characterized as a plasma membrane Nadependent Pi transporter. (5, 6) The skeletal expression of PiT1 and its regulation by hormonal or local chondrocytic and osteogenic differentiation factors have led to the assumption that PiT1 represents an instrumental Pi transporter during the mineralization process. (7) (8) (9) However, gathering evidence of a role of PiT1 in skeletal mineralization has been hampered by the embryonic lethality of mice lacking PiT1. (10, 11) Our initial attempt to illustrate the role of PiT1 in bone mineralization using PiT1 hypomorphic mice was also impeded by generalized anemia and incomplete PiT1 deletion in this model. (12) Importantly, the high quantity of Pi needed for ECM mineralization is at odd with the poor transporting capacity of PiT1, (13) suggesting that the involvement of PiT1 in skeletal physiology may relate to yet unknown functions of PiT1.
The bulk of secreted or membrane-bound proteins enter the endoplasmic reticulum (ER), where they fold and assemble. When the ER protein-folding capacity is overloaded, unfolded proteins trigger the activation of intracellular signaling pathways collectively termed the unfolded protein response (UPR). (14) The UPR upregulates genes encoding for molecular chaperones, oxidoreductases, and ER-associated degradation (ERAD) components, resulting in a reduced load of processed proteins, enhanced folding capacity, and increased degradation of misfolded proteins. (14) This UPR is particularly important and robust in chondrocytes and allow them to cope with the massive load of ECM proteins synthesized in the ER. Prolonged ER stress, however, results in an UPR-dependent apoptosis, characterized by the upregulation of CCAAT/enhancerbinding protein (C/EBP) homologous protein (Chop). (15) An imbalance of the folding and/or secretion of ECM proteins is involved in the pathogenesis of many connective tissue disorders such as pseudoachondroplasia (PSACH) and autosomal dominant multiple epiphyseal dysplasia (MED). (16) XBP1 and ATF4 are two of the main transcription factors involved in mediating the UPR pathway. (14) Interestingly, the phenotype of PiT1 global knockout (KO) mice is reminiscent of Xpb1 and Atf4 null mice, (10, 17, 18) which is suggestive of a yet unknown functional crosstalk between PiT1 and the UPR. This observation underscores an unidentified role of PiT1 in cartilage, which we addressed by cell-specific and temporally-controlled PiT1 ablation in the chondrocytic lineage.
Materials and Methods

Animal experimentation and ethics
Generation of PiT1 lox/lox and Agc1 tm(IRES-creERT2) has been described. (10, 19) Chondrocyte-specific deletion of PiT1 was performed by crossing PiT1 lox/lox to Agc1 CreERT2/+ ;PiT1 lox/+ mice to generate littermate control (Agc1 +/+ ;PiT1 lox/lox ) and mutant (Agc1 CreERT2/+ ;PiT1 lox/lox ) mice that were injected intraperitoneally with 300 mg of tamoxifen (Sigma-Aldrich) at 3 days of age (P3). Thereafter in the manuscript, Agc1 +/+ ;PiT1 lox/lox mice are denoted "Ctrl," whereas Agc1 CreERT2/+ ;PiT1 lox/lox mice are denoted "PiT1 cKO ." To ensure that the observed phenotype did not originate from an artifactual Cre and/or tamoxifen effect, additional control mice were obtained from Agc1 CreERT2/+ ; PiT1 lox/+ Â PiT1 lox/+ crossings to generate Cre-positive PiT1 +/+ mice (Agc1 CreERT2/+ ;PiT1 +/+ ) that were injected with tamoxifen. No difference could be seen between these additional control mice and the Cre-negative (Agc1 +/+ ;PiT1 lox/lox ) control mice used in this study. In addition, no difference could be seen between tamoxifen-injected control animals (both Cre-negative and Crepositive control mice) and mice that were not injected with tamoxifen. Genomic DNA from tail was used for PCR genotyping. Primers used to assess allelic recombination by PCR are reported in Supplementary Table 1 . Animal care and maintenance were provided through the University of Nantes accredited animal facility at the Unit e de Th erapeutique Exp erimentale (Nantes, France). Mice were viable, fertile, and bred normally and were housed under pathogen-free conditions. All procedures were approved by the Animal Care and Use Committee of the R egion Pays de la Loire and conducted according to the French and European regulations on care and protection of laboratory animals (EC Directive 86/609, French Law 2001-486 issued on June 6, 2001) and to the National Institutes of Health Animal Welfare (project #02286.02).
Tissue sample processing and histological staining
Humeri were fixed in 4% paraformaldehyde in phosphate buffer saline (PBS; Thermo Fisher Scientific) during 24 to 48 hours and decalcified in 0.5M EDTA pH 8.0 before being embedded in paraffin (Leica TP1020 automated tissue processor). Serial 4-mmthick sections for histological staining or immunohistochemistry (IHC) were obtained using a microtome (Microtome 2050 ® ; Reichert Jung). Staining of sections with Alcian blue, Harris' hematoxylin, and Safranin-O were carried out using standard histological procedures, as described. (12) IHC and TUNEL assay Paraffin-embedded sections were processed for IHC as described. (10) Specific antigen retrieval conditions and list of antibodies used are reported in Supplementary Table 2 . Stained sections were then mounted with Eukitt ® and scanned using a Hamamatsu NanoZoomer HT (Hamamatsu Photonics KK) digital scanner at magnification Â40. To reveal apoptotic cells, the DeadEndTM fluorimetric TUNEL system (Promega) was used according to the manufacturer's instructions.
Cell culture and immunofluorescence studies
Primary chondrocytes were isolated from PiT1 cKO mice as described (20) and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. Undifferentiated ATDC5 cells were maintained in DMEM:F12 medium supplemented with 5% FBS. For differentiation experiments, ATDC5 were cultured in cell monolayer for 28 days in DMEM:F12 medium supplemented with 5% FBS in the presence of 10 mg/mL bovine insulin, 10 mg/mL human transferrin, and 3 Â 10 -8 M sodium selenite, as described. (21) HEK293T cells were maintained in DMEM supplemented with 10% FBS. For immunofluorescence studies, cells were fixed in cold methanol and blocked in 1% bovine serum albumin in PBS for 1 hour at room temperature (RT). Incubations with specific antibodies were performed overnight at 4°C. The list of antibodies used is reported in Supplementary  Table 2 . Images were acquired with a confocal microscope (Nikon Eclipse C1).
Transfections and transductions
For lentiviral-based deletion of PiT1, shRNA targeting PiT1 and shScramble sequences (22) were introduced in the pSicoR backbone (Addgene). Viral infection was conducted as described above. To overexpress the transport-deficient mutant of PiT1, the S621A mutation was introduced into the PiT1 sequence (22) and the DNA constructs containing either wildtype (WT) PiT1 or PiT1 S621A were inserted in the lentiviral vector pHAGE-CMV-MCS-IRES-ZsGreen (PlasmID Repository; Harvard Medical School, Boston, MA, USA). ATDC5 were infected with lentivirus particles overnight and the media were refreshed on the next morning. To transiently inactivate UPR transcription factors, ATDC5 cells were transfected with sequence specific siRNAs (100nM) from Dharmacon (Chicago, IL, USA) using oligofectamine (Thermo Fisher Scientific). Transductions and transfections were also conducted in primary chondrocytes. To rescue the vascular endothelial growth factor A (Vegf-A) cellular retention, primary chondrocytes were transfected with the transport-deficient mutant plasmid PiT1 S621A using JetPrime 
Gene expression analysis
Total RNA was isolated from cells or tissues using the Nucleospin ® RNA II kit (Macherey-Nagel, D€ uren, Germany) according to the manufacturer's instructions. RNA was reverse transcribed using SuperScript ® III (Thermo Fisher Scientific) as per the manufacturer's instructions. Real-time PCR (qPCR) was performed on a Bio-Rad CFX96 using SYBR ® Select Master Mix (Thermo Fisher Scientific). Primer efficiency was determined using a standard curve with a 1:4 dilution and specificity of amplification was verified from the melting curve analysis. Expression of target genes were normalized to pinin (Pnn) or glucuronidase B (GusB) expression levels and the relative gene expression levels were calculated as described. (23) The sequences of primers used in this study are listed in Supplementary  Table 3 . Analysis of Xbp1 splicing was performed by RT-PCR using the following primers: 5 0 -GAACCAGGAGTTAAGAACACG-3 0 and 5 0 -AGGCAACAGTGTCAGAGTCC-3 0 .
Immunoblot analysis
Cells were lysed for 30 min in ice-cold lysis buffer (150mM NaCl, 10mM Tris HCl pH 8, 5mM EDTA, 1% NP40, 0.1% SDS, 0.5% Nadeoxycholate, and a protease inhibitor cocktail from Roche), the protein extract was resolved by NuPAGE© Novex 4-12% SDS-PAGE (Thermo Fisher Scientific) and electroblotted onto polyvinylidene fluoride (PVDF) membranes. After blocking with nonfat dry milk/Tris-buffered saline Tween-20 (TBST), blots were probed with primary and secondary horseradish peroxidase (HRP) antibodies and revealed with ChemiDoc Imaging SystemTM (Bio-Rad). The list of antibodies and the specific experimental conditions used in this study are reported in Supplementary Table 2 .
Coimmunoprecipitation
Transfected ATDC5 cells were washed with ice-cold PBS, and lysed with lysis buffer (50mM NaCl, 1% Nonidet P-40, 20mM EDTA, 0.5% sodium deoxycholate, 50mM Tris HCl, pH8, and protease phosphatase inhibitor cocktail). Cell debris was removed by centrifugation at 14,000g for 10 min. Equal amounts of cell lysates were used for immunoprecipitation with anti-PiT1 or anti-Pdi using protein A/G ultralink resin (Thermo Fisher Scientific). Immunoprecipitates were washed four times with lysis buffer, boiled in Laemmli buffer, and immunoblotting was performed as described in Immunoblot analysis section.
ELISA
Determination of Vegf-A in supernatant of primary chondrocytes was performed with the Murine Vegf Mini ABTS ELISA Development Kit (Peprotech). The Vegf-A levels were normalized with total protein content in each sample.
Transmission electron microscopy
Samples were harvested and fixed (2% glutaraldehyde, 0.2M sodium cacodylate buffer pH 7.2) for 1.5 hours at 4°C, then washed overnight at 4°C in 0.2M sodium cacodylate buffer pH 7.2. Postfixation was carried out with 2% osmium for 1 hour, and samples were washed three times in distilled water. Samples were dehydrated in ethanol, washed with propylene oxide twice for 15 min, and impregnated with a 1:1 ratio of propylene oxide: epon overnight. This was then replaced with 100% of epon for 5 hours before polymerization was performed for 24 hours at 37°C and 48 hours at 60°C. Ultra-thin sections (70 to 80 nm) were examined with a JEM-1010 microscope (JEOL), operating at an accelerated voltage of 80 kV.
Yeast two-hybrid screen
Yeast experiments were performed by Hybrigenics (Paris, France). The library used for the screen was isolated from human placenta. The large intracellular loop (denominated iLoop1 thereafter) of human PiT1 (from amino acids 250 to 510) was used as a bait for the screen because the largest sequence differences between PiT1 and PiT2 were found in this region of the protein.
Expression and purification of murine iLoop1
The sequence corresponding to amino acids 250 to 510 of murine PiT1 (iLoop1) was cloned into the expression vector pcDNA6 V5-6His using Fastcloning. (24) HEK293T cells were transfected with 1 mg pcDNA6-iLoop1 plasmid and iLoop1 was purified using a EN-NTA spin columns kit (Qiagen), following the manufacturer's instructions. Briefly, cells were lysed 48 hours after transfection in 50mM NaH 2 PO 4 , 300mM NaCl, and 10mM imidazole pH 8.0. After lysate clearing by centrifugation, the supernatant was loaded on nickel-chelating resin NTA and iLoop1 was eluted in 500mM imidazole. Dialysis of purified protein was performed overnight at 4°C in a saline buffer (150mM NaCl and 20mM Tris-HCl pH 7.5) to remove imidazole.
Pdi activity assay
Pdi activity was monitored as described. (25) ATDC5 cells were harvested, resuspended in a suspension buffer (50mM Tris-HCl pH 7.5, 25mM KCl, and 5mM MgCl 2 ) sonicated and centrifuged at 11,000g for 10 min. Proteins were added in 200 mL of reaction mix (100mM potassium phosphate pH 7.0, 2mM EDTA pH 7.5, 100mM bovine insulin, and 2mM DTT) and Pdi activity was monitored as measured by increased turbidity at optical density (OD) 660 nm for 30 min. Controls containing recombinant PDI, reaction buffer, and insulin substrate, but no ATDC5 cell lysate was used as a blank. The OD660 value of this blank was subtracted to experimental values obtained with ATDC5 cells lysates.
Bioinformatics analysis
Transcription factor binding site prediction was performed on the proximal 5-kb region of the murine PiT1 promoter using MatInspector software suite (Genomatix). Conservation of ER growth plate defects are indicated with white (proliferative zone) and black (hypertrophic zone) arrowheads. Scale bar ¼ 200 mm. (C) RT-qPCR analysis of mRNA levels in primary rib chondrocytes harvested 24 hours p.i. Data are expressed as means AE SE. ÃÃ p < 0.01 versus Ctrl, n ¼ 3. (D) mRNA levels of indicated genes in untransfected (Ctrl; black bars) or PiT1-depleted (shPiT1; white bars) ATDC5 cells differentiated during 28 days in presence of 10 mg/mL insulin, as assayed by RT-qPCR. Data are expressed as means AE SE. Ã p < 0.05, ÃÃ p < 0.01 versus Ctrl, n ¼ 4. (E) Alcian blue staining of Control (Ctrl) or PiT1depleted (shPiT1) ATDC5 cells differentiated in presence of 10 mg/mL insulin. (F) Body weight of control and PiT1 cKO mice 19 days p.i. and gross appearance 19 days p.i. Ã p < 0.05 versus Ctrl, n ¼ 5. H ¼ hypertrophic zone; P ¼ proliferative zone; p.i. ¼ post-tamoxifen injection. 
Results
Targeted disruption of PiT1 in chondrocytes impairs endochondral ossification
To investigate the role of PiT1 in endochondral ossification, we crossed conditional PiT1 lox/lox mice (10) with Agc1 tm(IRES-creERT2) transgenic mice (19) to generate PiT1 lox/lox ;Agc1 tm(IRES-creERT2) mutant mice (denominated PiT1 cKO thereafter) ( Supplementary  Fig. 1A ). We injected pups with tamoxifen at postnatal day 3 (P3) to induce the Cre-mediated deletion of PiT1 exon 5, leading to PiT1 functional invalidation in femoral epiphyses as soon as 8 hours post-tamoxifen injection (p.i.) ( Supplementary Fig. 1B ). (10) Cre induction was associated with a stable decrease in mRNA expression encoding the WT PiT1 in epiphysis chondrocytes over time ( Supplementary Fig. 1C ), and with a rapid decrease in PiT1 protein abundance in PiT1 cKO chondrocytes ( Fig. 1A) . PiT1 ablation did not lead to overexpression of the PiT1 paralog PiT2 ( Fig. 1 A, Supplementary Fig. 1D ), thus excluding a possible PiT2-driven compensatory mechanism. Histological analyses of proximal humerus epiphyses 7 days p.i. revealed the presence of an inverted drop-like shaped hypocellular zone in the center of the growth plate of PiT1 cKO mice (Fig. 1B) , which was visible as soon as 24 hours p.i. ( Supplementary Fig. 1E ). Twelve days later, this hypocellular zone had disappeared and a reduction in the area of the type X collagen-positive hypertrophic layer could be observed (the percentage of hypertrophic area versus total growth plate area was 18.9 AE 0.6% in WT and 14.6 AE 3% in cKO) ( Fig. 1B) . Consistent with these growth plate abnormalities, the expression of chondrocytic markers in primary cultures of PiT1depleted chondrocytes and in the PiT1-depleted ATDC5 chondrogenic cell line decreased significantly, as did the synthesis of glycosaminoglycan synthesis (Fig. 1C-E) .
The cellular growth plate abnormalities caused by postnatal deletion of PiT1 in cartilage resulted in reduced body size and weight (Fig. 1F) . Because PiT1 has been characterized as a phosphate transporter (5) and phosphate is an essential component of hydroxyapatite crystals, we investigated the mineralization of the mutant growth plate and bones of control and mutant P22 mice by Von Kossa and Trichrome-Masson staining. Quantification of the cortical and trabecular mineralized area showed no difference between genotypes, and no overt osteoidosis was observed in mutant bones (Supplementary Fig. 1F , data not shown). When chondrocytes isolated from control and mutant mice were cultured using 3D high-density micromasses, no difference in mineralization and expression of genes involved in mineralization pathways, such as Alpl and Phospho1, was detected ( Supplementary Fig. 1G, H) , suggesting the absence of chondrocyte-autonomous defect in mineralization mechanisms. Overall, these data support the idea that PiT1 is required for the growth plate maturation process, but not for the mineralization potential of growth plate chondrocytes.
PiT1 depletion in cartilage induces ER stress and chondrocyte death
To understand the growth plate defect observed in PiT1 mutant mice, we analyzed mutant growth plates early after tamoxifen injection. Eight hours following PiT1 ablation, Alcian blue staining of proximal humeri revealed intracellular glycosaminoglycan retention in P3 PiT1 cKO chondrocytes, specifically in the center of the growth plate ( Fig. 2A ). This was associated with a swelling of cells, with no change in type II and X collagen immunostaining ( Supplementary Fig. 2A, B) . In central growth plate chondrocytes, aggrecan was retained within the cells and co-localized with the ER marker ERp46 (as shown by confocal microscopy and the white arrows in Fig. 2B ), whereas other matrix proteins such as cartilage oligomeric protein (COMP) were not retained ( Supplementary Fig. 2C ). Consistent with the retention of aggrecan, a low content of Alcian blue-stained extracellular mature glycosaminoglycans was observed 48 hours postablation in the center of the PiT1 cKO growth plate (Fig. 2C ). No significant difference in the proportion of BrdU-positive chondrocytes was detected between control and PiT1 cKO growth plates 48 hours or 7 days post-PiT1 ablation ( Supplementary  Fig. 2D ). In contrast, TUNEL analyses showed a massive cell death specifically in the center of mutant growth plates 3 days post-PiT1 ablation (Fig. 2D) , underscoring the role of PiT1 in chondrocyte survival. The effect of PiT1 deletion on chondrocyte survival was visible as early as 8 hours p.i. and was not observed in the hypertrophic layer ( Supplementary Fig. 2E ), nor in absence of terminal deoxytransferase (negative control, Supplementary Fig. 2F ). In addition, when examining the spatial expression of Sox9 and Pth1r, which are well known to control the synchronization of chondrocyte differentiation with other critical processes of endochondral bone development, such as cartilage matrix mineralization, we did not observe major differences between genotypes ( Supplementary Fig. 3 ). These data indicate that deletion of PiT1 postnatally, although not overtly altering bone growth and mineralization, induces a transient and localized phenotype in the hypoxic region of the growth plate, at a stage characterized by sustained ECM synthesis and bone growth.
The accumulation of aggrecan in the ER of mutant cells and the cell death associated with PiT1 loss-of-function suggested that PiT1 cKO growth plate chondrocytes may experience an uncompensated ER stress. To address this possibility, we performed ultrastructural analyses by transmission electron microscopy (TEM) 8 hours post-tamoxifen injection. Transverse semi-thin sections of humerus epiphyses showed a welldeveloped and organized rough ER in both the peripheral and central zones of the WT growth plate ( Fig. 2E, F, upper  panels) , whereas PiT1 cKO growth plates presented with a mild distended ER in the peripheral zone but a more distended and fragmented ER in central zone mutant chondrocytes ( Fig. 2E , F, lower panels), which are both a hallmark of ER-stressed cells. The ER stress experienced by PiT1-depleted growth plate chondrocytes in vivo was also revealed by the strong central expression of Chop, one of the main target of the UPR pathway activated during ER stress (27) (Fig. 2G, Supplementary Fig. 4A ), and the increase of the UPR-activated protein caspase-12 staining throughout the growth plate (28) (Fig. 2G , Supplementary  Fig. 4B ). In cultured ATDC5 cells, shRNA-mediated PiT1 depletion further supported these results by showing a distended ER network ( Supplementary Fig. 4C ) and increased Chop and Casp12 protein expression ( Supplementary Fig. 4D ). In addition, Chop, Atf4, and Bip expression was increased in PiT1 cKO chondrocytes compared to controls (Fig. 2H) . The splicing of the ER stress marker Xbp1 was also increased in shPiT1transduced chondrocytes, thus confirming that depletion of PiT1-triggered ER stress (Fig. 2I ). shRNA-mediated PiT1 depletion increased Chop mRNA whereas overexpression of a Pi transportdeficient mutant of PiT1 (22, 29) led to the opposite effect ( Fig. 2J ), suggesting that ER homeostasis is modulated by PiT1 independently from its Pi transport function.
PiT1 is an ER-stress regulated gene modulating Pdi activity
To further determine the role of PiT1 in ER homeostasis, we investigated its expression in the ER and its regulation by the UPR pathway. Immunofluorescence analyses performed in ATDC5 cells revealed that PiT1 mainly co-localized with the ER marker ERp46, suggesting that it was mainly expressed in the ER compartment (Fig. 3A) . When ATDC5 cells were stimulated with the ER stress inducer tunicamycin for 8 or 24 hours, Chop mRNA and protein levels were significantly increased, as expected, but PiT1 expression was found to be upregulated as well ( Fig. 3B, Supplementary Fig. 5A ). In line with this result, blocking the expression of the main UPR transcription factors XBP1s, ATF6N, and ATF4 repressed the expression of PiT1 in tunicamycin-treated cells (Fig. 3C ). Furthermore, we identified evolutionary conserved putative binding sites for XBP1s, ATF6N, and ATF4 in the proximal 1-kb region of the mouse PiT1 promoter ( Supplementary Fig. 5B ). Last, when the 5 0flanking region of the PiT1 gene was inserted upstream of a luciferase reporter gene sequence, it was able to be transactivated by UPR mediators; although XBP1s alone was not able to transactivate the PiT1 promoter, ATF4 and ATF6N increased the basal activity of the PiT1 promoter 4.0-fold and 2.5-fold over controls, respectively ( Supplementary Fig. 5C ). Collectively, these data identify PiT1 is an ER stress-regulated gene.
To get a better insight into the role of PiT1 during ER homeostasis, we searched for potential PiT1 protein partners using a yeast two-hybrid screen method. Using this approach, we identified 20 potential PiT1 partners, among which the Protein Disulfide Isomerase family A member 1 (Pdi), stood out, as a high-confidence prey ( Supplementary Fig. 5D ). Because Pdi was described as a major ER chaperone involved in the folding of nascent peptides, (30) we investigated further the functional link between PiT1 and Pdi. We first confirmed the physical interaction between PiT1 and Pdi under basal conditions by coimmunoprecipitation in ATDC5 chondrocytes (Fig. 3D,  Supplementary Fig. 6 ). Interestingly, the immunoprecipitation results supported an increase in PiT1-Pdi interaction under ER stress conditions. In PiT1-depleted cells, ER stress did not impact the mRNA and protein expression, and cellular localization of Pdi ( Supplementary Fig. 5E-G) , but did reduce Pdi activity compared to control cells (Fig. 3E) , as measured by a Pdi activity assay based on the aggregation of the insulin B chain following its reduction by Pdi. (25) To confirm that PiT1 modulates Pdi activity, we performed a dose-response experiment in a cell-free system containing purified Pdi and various quantities of purified iLoop1, the large intracellular loop of PiT1 that was used as a bait in the yeast two-hybrid screen. Measuring solution turbidity as an indication of the insulin B chain aggregation induced by Pdi activity, we observed a dose-dependent increase in Pdi activity (Fig. 3F ). Altogether, these results strongly suggest that PiT1 is an ER stress-regulated gene that stimulates the activity of the ER chaperone Pdi. Therefore, it is expected that in case of PiT1 depletion, the resulting decrease in Pdi activity would cause ER stress, triggering the UPR.
The ER stress caused by PiT1 deficiency is associated with decreased Vegf-A secretion in the central hypoxic region of the growth plate
The uncompensated ER stress triggered by PiT1 deletion occurred mainly in the central region of the epiphysis, which is known to be hypoxic, (31) thus suggesting a possible functional interaction between PiT1, the hypoxia pathway and its main target Vegf-A. Immunofluorescence analysis of PiT1 cKO growth plates 8 hours post-PiT1 ablation showed intense Vegf-A staining in chondrocytes from the central epiphysis region compared to controls and to the non-hypoxic region of the same growth plate (Fig. 4A ), which arose in absence of induction of epiphyseal Vegf-A mRNA expression (Fig. 4B) . The latter may be due to the relative small size of the central hypoxic zone compared to the rest of the epiphysis. However, when primary chondrocytes from both control and PiT1 cKO mice were cultured in low oxygen tension (1%), Vegf-A and Pgk1 mRNA expression was upregulated in control and PiT1 cKO cells (Fig. 4C ), suggesting that PiT1 deletion in growth plate chondrocytes does not impair cell response to hypoxia. However, hypoxia reduced the expression of PiT1 in WT chondrocytes (Fig. 4C ) and increased the expression of UPR markers both in Control or PiT1-depleted cells ( Supplementary Fig. 7A ). Together, these data suggest that both the deletion of PiT1 (induced genetically in PiT1 cKO mice) and the hypoxic condition of the central growth plate area (leading to further reduced PiT1 expression) contribute to the uncompensated ER stress leading to impaired Vegf-A secretion. Further supporting the idea that PiT1 depletion impairs Vegf-A secretion, we detected a decrease in Vegf-A secretion in the supernatant of PiT1-depleted primary hypoxic chondrocytes by ELISA (Fig. 4D) , associated with an increase in cellular Vegf-A protein content ( Supplementary Fig. 7B , comparing lane 5 to lane 12). Importantly, we could rescue the high Vegf-A cellular content of PiT1-depleted chondrocytes by reexpressing a phosphate transporter-deficient form of PiT1 (Fig. 4E , Supplementary Fig. 7B comparing lane 12 to lanes 13 and 14) . Collectively, these data support a model whereby in the hypoxic environment typical of the central growth plate, PiT1 is required for normal ER homeostasis and secretion of factors crucial for growth plate homeostasis, independently of its Pi transport function.
Discussion
In the present study, we identified a role of PiT1 in ER homeostasis maintenance during endochondral ossification via detailed analysis of a chondrocyte-specific and temporallycontrolled PiT1-deficient mouse model. We show that PiT1 in chondrocytes is mainly expressed in the ER, and not at the cell surface, thus challenging its role as the main phosphate transporter in this cell lineage, and strengthening its role in ER homeostasis. Accordingly, we show that PiT1 expression is upregulated under ER stress conditions, a feature shared by genes involved in UPR-related events. In addition, we show that PiT1 expression is regulated by the three main UPR transcription factors and mainly by ATF4, a finding consistent with a recent study conducted in vascular smooth muscle cells. (32) The importance of PiT1 in ER homeostasis is further documented by (i) its interaction with Pdi, an ER chaperone strongly induced in ER stress conditions and involved in the formation of disulfide bonds in newly synthesized proteins (30, 33, 34) ; (ii) the dosedependent modulation of Pdi reductase activity by PiT1; and (iii) the impaired secretion of proteoglycans and Vegf-a in PiT1deficient chondrocytes in the hypoxic center of the growth plate.
Interplay between PiT1, ER homeostasis, and hypoxia
Although genes involved in UPR are known to mediate the response to unfolded or misfolded proteins in the ER, they have also been described to be required for the maturation of chondrocytes during endochondral ossification. (35) For instance, Atf4 deficiency in chondrocytes leads to delayed endochondral ossification, short stature, and disorganization of the growth plate. (36) Similarly, disruption of Xbp1 leads to delayed ossification, (37) whereas overexpression of Xbp1 in ATDC5 chondrocytes increases the expression of the hypertrophic markers ColX and Runx2. (38) Moreover, because Atf4 has been shown to be involved in other integrated stress responses, the regulation of PiT1 by this transcription factor may reveal roles in other physiological mechanisms. (32, 39) Interestingly, the decrease in Pdi activity and increase in ER stress detected in PiT1 cKO chondrocytes are associated with reduced expression of chondrocyte differentiation markers, in line with the notion that ER stress and the UPR pathway are critical for adequate growth plate maturation during endochondral bone formation. Although more work is needed to understand the mechanistic link between PiT1, Pdi, Supplementary Fig. 4 ). Cells were transfected either with shScramble or shPiT1, together with empty plasmid (pcDNA6) of plasmid expressing wild-type (PiT1wt) or transport-deficient mutant (PiT1mut) PiT1, as indicated. Band intensity was normalized either using b-actin or b-tubulin. n ¼ 3. endochondral bone formation, and ER stress, our experiments ( Fig. 3D, Supplementary Fig. 5D ) suggested that the Pdi chaperone may interact with the fourth intracellular loop of PiT1 (iLoop1) through its b 0 -x-linker-a 0 hinged motif. (40, 41) This specific region of Pdi is involved in a pH-dependent conformational change during ER stress, allowing its preferential interaction with reduced/unfolded or mis-oxidized proteins. (34) Hence, an interaction of PiT1 with the b 0 -x-linker-a 0 region would interfere with Pdi activity and explain the dose-dependent PiT1 modulation of Pdi reductase activity reported herein. Although the lack of reliable PiT1 antibody for IHC prevents the possibility to study PiT1-Pdi co-localization in different physiological conditions, one can imagine that if PiT1 depletion leads to a decrease in Pdi activity, it is expected that this deletion results in a global unbalance of ER folding capacity of chondrocytes, leading to a global defect in protein secretion. However, our data showed that PiT1 depletion in chondrocytes led to an intracellular accumulation of aggrecan but not collagen or COMP, arguing against this idea. Similarly, defects in the secretion of Vegf-A, but not transforming growth factor b (Tgf-b) or growth/differentiation factor 5 (Gdf5) were observed ( Supplementary Fig. 7C, D) , indicating that chondrocytic secretion is not globally affected in absence of PiT1. Although more investigation is needed to decipher the underlying mechanisms, this observation may be consistent with the existence of distinct ER sorting mechanisms for different matrix molecules, as shown in chondrocytes of pseudoachondroplasia patients (PSACH) and in other studies. (42) (43) (44) The defect in chondrocyte differentiation observed in cKO mice may also result in part from indirect consequences of PiT1 deletion, such as cell death in the hypoxic central zone. Indeed, phenotypic analysis of PiT1 cKO growth plates showed that uncompensated ER stress was visible throughout the entire epiphysis of mutant mice, with no loss of cell viability under normal oxygen tension conditions. This indicated that the uncompensated ER stress phenotype alone was not sufficient to affect the survival of mutant chondrocytes. Therefore, it is likely that the absence of PiT1 in growth plate chondrocytes, associated with the low oxygen tension present in the central area of the mutant growth plates result in a loss of cell survival. This observation is reminiscent of the ER stress-induced upon deletion of Hif1a that caused cell death in the hypoxic cartilage. (45) It is therefore possible that instead of a global uncompensated ER stress known to trigger cell death, (46) a specific change in the quality of ECM proteins synthesized by chondrocytes and a defect in Vegf-A secretion may be involved, because these factors are crucial for chondrocyte survival. (45, 47, 48) PiT1 mechanism of action Although more work remains to be done to discriminate between the specific roles of each player, it is noteworthy that we were able to reduce the defect in UPR and rescue the Vegf-A secretion defect by overexpressing a transport-deficient PiT1 mutant in PiT1-depleted chondrocytes. This argues against a major role of PiT1-driven Pi transport in the observed ER phenotype, and is consistent with (i) the weak expression of this transporter at the extracellular plasma membrane, and (ii) the absence of abnormal mineralization in the bone of cKO mice. This also complements the growing evidence that PiT1 is a membrane-associated protein whose functions go beyond its previously established role of Na-Pi co-transporter. (5, 6) Indeed, this historical function led the scientific community to hypothesize that PiT1 could mediate the transport of Pi necessary for the mineralization of the skeleton. However, in vivo experiments using transgenic mice overexpressing PiT1 (49) or genetically modified mouse models underexpressing PiT1 (12) have failed to demonstrate a major contribution of this transporter to mineralization processes. This data are in line with our current observation that deleting PiT1 in cartilage does not impact mineralization per se.
Pi-transport-dependent and Pi-transport-independent actions of PiT1 have already been described, and are not shared by its paralog PiT2: PiT1 is involved in very diverse cellular processes, such as cell proliferation and adhesion, (22, 50, 51) tumor necrosis factor (TNF)-induced apoptosis, (29) or Pi-dependent activation of the ERK1/2 MAPK pathway. (52) (53) (54) PiT1 is also involved in pathological vascular calcifications (55) ; liver development (10) ; erythroid and B cell differentiation (10, 56, 57) ; and enhanced insulin signaling and decreased hepatic lipogenesis. (58) Based on these observations, we hypothesized that the multifunctional nature of PiT1 comes from the recruitment or sequestration of specific cellular proteins, which can modulate their activities. Because the largest protein sequence differences between PiT1 and PiT2 are found in their large cytoplasmic iLoops, (22) which is not involved in Pi-transport function, (59) (60) (61) (62) we conducted a two-hybrid screen leading to the identification of Pdi as a PiT1 protein partner. Our results are consistent with the possibility that the Pi-transport function of PiT1 does not contribute to the observed phenotype, but rather that PiT1 helps maintain ER homeostasis through its binding to Pdi. A defect in PiT1-Pdi interaction would decrease Pdi activity, leading to an uncompensated ER stress, which, in the central hypoxic region of the growth plate, would lead to secretion defects of Vegf-A and aggrecan, and subsequent cell death. More investigations are required to determine the impact of PiT1 deletion on distinct secretory pathways or ER sorting mechanisms, and to identify what other secreted molecules might be affected. Another aspect to take into consideration when trying to define the role and mode of action of PiT1 in chondrocytes, is the fact that our data were obtained using an inducible Cre mouse model. It is possible that the phenotypical consequences of PiT1 deletion earlier in development would diverge from our observations leading to abnormal skeletal development.
In summary, our work reveals a novel Pi-independent function of PiT1 in the regulation of ER homeostasis in chondrocytes, necessary for the maintenance of growth plate chondrocyte differentiation and survival during endochondral ossification.
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